Saham Orang Dalam | 5,551 shares |
Orang Dalam Sejati | 25 |
Skor Sentimen Orang Dalam
Skor Sentimen Orang Dalam mengidentifikasi perusahaan yang dibeli oleh orang dalam korporat.
Ini adalah hasil dari model kuantitatif multifaktor yang canggih yang mengidentifikasi perusahaan dengan tingkat akumulasi internal tertinggi. Model penilaian ini menggunakan kombinasi dari jumlah bersih orang dalam yang membeli dalam 90 hari sebelumnya, total saham yang dibeli sebagai persentase dari jumlah saham yang beredar, dan total saham yang dimiliki oleh orang dalam. Angka tersebut berkisar dari 0 hingga 100, dengan angka yang lebih tinggi menunjukkan tingkat akumulasi yang lebih tinggi dibandingkan dengan perusahaan sejenis, dan 50 adalah rata-rata.
Frekuensi Pembaruan: Setiap Hari
Skor Sentimen Petugas
Skor Sentimen Pejabat menemukan perusahaan yang dibeli oleh Pejabat Korporat.
Menurut definisi, Pejabat Korporasi adalah Orang Dalam Korporasi, tetapi tidak seperti beberapa Orang Dalam lainnya (Pemegang Saham 10% dan Anggota Dewan), Pejabat bekerja untuk perusahaan setiap hari, dan mereka menggunakan uang mereka sendiri saat bertransaksi . (Pemegang Saham 10% dan Anggota Dewan seringkali adalah manajer dana yang mengelola uang orang lain.) Dengan demikian, transaksi orang dalam yang dilakukan oleh Pejabat jauh lebih signifikan dan harus ditangani dengan tepat.
Seperti Skor Sentimen Internal, Skor Sentimen Pejabat adalah hasil dari model kuantitatif multi-faktor yang canggih yang mengidentifikasi perusahaan dengan tingkat akumulasi pejabat tertinggi.
Frekuensi Pembaruan: Setiap Hari
Metrik Utama Orang Dalam
Kartu ini menunjukkan peringkat perusahaan berdasarkan berbagai metrik internal. Peringkat persentil menunjukkan bagaimana perusahaan ini dibandingkan dengan perusahaan lain di pasar AS. Peringkat yang lebih tinggi menunjukkan situasi yang lebih baik.
Sebagai contoh, secara umum diterima bahwa pembelian oleh orang dalam perusahaan adalah indikator positif, sehingga perusahaan dengan lebih banyak pembelian oleh orang dalam akan mendapat peringkat lebih tinggi daripada perusahaan dengan lebih sedikit pembelian oleh orang dalam (atau bahkan penjualan oleh orang dalam).
Jumlah Bersih Pembelian oleh Orang Dalam (Peringkat)
0 ( )
6076 out of 11305Jumlah Bersih Pembelian oleh Orang Dalam adalah total jumlah orang dalam yang membeli dikurangi total jumlah orang dalam yang menjual dalam 90 hari terakhir. Peringkat persentil ditunjukkan di sini (kisaran dari 0 hingga 100%).
Persentase Saham yang Dibeli oleh Orang Dalam (Peringkat)
0.000 %( )
6017 out of 11224Persentase Saham yang Dibeli oleh Orang Dalam adalah total jumlah saham yang dibeli oleh orang dalam dikurangi total jumlah saham yang dijual oleh orang dalam dalam 90 hari terakhir, dibagi dengan total jumlah saham yang beredar dan dikalikan dengan 100.
Grafik Perdagangan Orang Dalam
Grafik berikut menunjukkan BlackRock Health Sciences Trust transaksi orang dalam. Orang dalam adalah pejabat, direktur, atau investor signifikan dalam suatu perusahaan. Secara umum, melakukan transaksi di perusahaan mereka berdasarkan informasi material yang belum dipublikasikan adalah ilegal bagi orang dalam. Ini tidak berarti bahwa mereka dilarang melakukan transaksi apa pun di perusahaan mereka sendiri. Namun, mereka wajib melaporkan semua transaksi kepada SEC melalui Formulir 4.
Daftar Orang Dalam dan Metrik Profitabilitas
Tabel ini menampilkan daftar orang dalam yang diketahui, dan dibuat secara otomatis dari pengajuan yang diungkapkan kepada SEC. Selain nama, jabatan terbaru, dan sebutan direktur, pejabat, atau pemilik 10%, kami memberikan kepemilikan terbaru yang diungkapkan. Selain itu, jika memungkinkan, kami memberikan kinerja perdagangan historis untuk orang dalam tersebut. Kinerja perdagangan historis adalah rata-rata tertimbang dari kinerja transaksi pembelian pasar terbuka aktual yang dilakukan oleh orang dalam tersebut. Untuk informasi lebih lanjut tentang bagaimana ini dihitung, tonton webinar YouTube ini.
See our leaderboard of most profitable insider traders.
Orang Dalam | Rata-rata Keuntungan (%) | Saham Dimiliki |
Terbagi Disesuaikan |
---|---|---|---|
Christopher Accettella - | 821 | 821 | |
Janey Ahn | 0 | ||
Richard Cavanagh | 1,691 | ||
Michael J Castellano Director - [D] | 400 | 400 | |
Robert Crothers | 0 | ||
Jonathan Diorio | 0 | ||
Cynthia Egan Director - [D] | 3,737 | 3,737 | |
Frank Fabozzi | 142 |
Orang Dalam | Rata-rata Keuntungan (%) | Saham Dimiliki |
Terbagi Disesuaikan |
---|---|---|---|
Kathleen F Feldstein | 484 | ||
James T Flynn | 882 | ||
Robert W Fairbairn | 0 | ||
Henry Gabbay Director - [D] | 0 | 0 | |
Robert Glenn Hubbard | 2,941 | ||
Jerrold B Harris | 2,373 | ||
W Carl Kester | 1,343 | ||
Jeffrey Gene Lee - | 0 | 0 |
Orang Dalam | Rata-rata Keuntungan (%) | Saham Dimiliki |
Terbagi Disesuaikan |
---|---|---|---|
Xiang Liu - | 0 | 0 | |
Lynch Catherine A. | 474 | ||
Kyle McClements - | 593 | 593 | |
Barbara Novick | 0 | ||
Charles Park | 0 | ||
John F Powers | 0 | ||
Karen P Robards | 619 | ||
Trent Walker | 0 | ||
H Erin Xie - | 0 | 0 |
Report errors via our new Insider Auditing Tool
Rekam Jejak Pembelian Orang Dalam - Analisis Keuntungan Jangka Pendek
Pada bagian ini, kami menganalisis profitabilitas setiap pembelian saham oleh orang dalam di pasar terbuka yang tidak direncanakan yang dilakukan di BME / BlackRock Health Sciences Trust. Analisis ini membantu memahami apakah orang dalam tersebut secara konsisten menghasilkan pengembalian abnormal, dan layak untuk diikuti. Analisis ini dilakukan selama satu tahun setelah setiap transaksi, dan hasilnya bersifat teoretis .
Tabel berikut menunjukkan pembelian pasar terbuka terbaru yang bukan bagian dari rencana perdagangan otomatis.
Harga yang Disesuaikan adalah harga yang disesuaikan dengan pemisahan saham. Ang Adjusted Shares ay ang jumlah saham yang disesuaikan dengan pemisahan saham (stock split).
Rekam Jejak Penjualan Orang Dalam - Analisis Kerugian Jangka Pendek
Dalam bagian ini, kami menganalisis penghindaran kerugian jangka pendek dari setiap penjualan dalam pasar terbuka yang tidak direncanakan oleh orang dalam yang dilakukan di BME / BlackRock Health Sciences Trust. Pola penghindaran kerugian yang konsisten dapat menunjukkan bahwa transaksi penjualan di masa mendatang dapat memprediksi penurunan harga. Analisis ini berlaku untuk satu tahun setelah setiap perdagangan, dan hasilnya bersifat teoretis .
Tabel berikut menunjukkan penjualan pasar terbuka terbaru yang bukan bagian dari rencana perdagangan otomatis.
Tanggal Perdagangan | Orang Dalam | Dilaporkan Saham |
Dilaporkan Harga |
Disesuaikan Saham |
Disesuaikan Harga |
Dasar Biaya | Hari-hari menuju Menit |
Harga di Menit |
Kerugian Maksimal Dihindari ($) |
Kerugian Maksimal Dihindari (%) |
---|---|---|---|---|---|---|---|---|---|---|
2014-12-09 | GABBAY HENRY | 650 | 42.1916 | 650 | 42.1916 | 27,425 | 293 | 36.5692 | -3,654 | -13.32 |
Harga yang Disesuaikan adalah harga yang disesuaikan dengan pemisahan saham. Ang Adjusted Shares ay ang jumlah saham yang disesuaikan dengan pemisahan saham (stock split).
Riwayat Transaksi
Klik ikon tautan untuk melihat riwayat transaksi lengkap. Transaksi yang dilaporkan sebagai bagian dari rencana perdagangan otomatis 10b5-1 akan memiliki tanda X di kolom yang bertanda 10b-5.
Berkas Tanggal |
Perdagangan Tanggal |
Formulir | Orang Dalam | Ticker | Judul Keamanan | Kode | Langsung | Latihan Harga |
Satuan Harga |
Unit Diubah |
Nilai Diubah (1 ribu) |
Sisa Pilihan |
Sisa Saham |
|
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2025-02-04 | 2025-01-31 | 4 | Xie H Erin | BME | Common Stock | D | 40.9200 | -13,471 | -551 | 0 | ||||
2025-02-04 | 2025-01-31 | 4 | Xie H Erin | BME | Common Stock | D | 13,471 | 13,471 | ||||||
2025-02-04 | 2025-01-31 | 4 | Liu Xiang | BME | Common Stock | D | 40.9200 | -281 | -11 | 0 | ||||
2025-02-04 | 2025-01-31 | 4 | Liu Xiang | BME | Common Stock | D | 281 | 281 | ||||||
2025-02-04 | 2025-01-31 | 4 | Accettella Christopher | BME | Common Stock | D | 40.9200 | -202 | -8 | 821 | ||||
2025-02-04 | 2025-01-31 | 4 | Accettella Christopher | BME | Common Stock | D | 202 | 1,023 | ||||||
2025-02-04 | 2025-01-31 | 4 | McClements Kyle | BME | Common Stock | D | 40.9200 | -641 | -26 | 593 | ||||
2025-02-04 | 2025-01-31 | 4 | McClements Kyle | BME | Common Stock | D | 641 | 1,234 | ||||||
2024-02-02 | 2024-01-31 | 4 | McClements Kyle | BME | Common Stock | D | 41.4800 | -626 | -26 | 2,736 | ||||
2024-02-02 | 2024-01-31 | 4 | McClements Kyle | BME | Common Stock | D | 626 | 3,361 | ||||||
2024-02-02 | 2024-01-31 | 4 | Xie H Erin | BME | Common Stock | D | 41.4800 | -14,947 | -620 | 0 | ||||
2024-02-02 | 2024-01-31 | 4 | Xie H Erin | BME | Common Stock | D | 14,947 | 14,947 | ||||||
2024-02-02 | 2024-01-31 | 4 | Accettella Christopher | BME | Common Stock | D | 41.4800 | -203 | -8 | 770 | ||||
2024-02-02 | 2024-01-31 | 4 | Accettella Christopher | BME | Common Stock | D | 203 | 972 | ||||||
2024-02-02 | 2024-01-31 | 4 | Liu Xiang | BME | Common Stock | D | 41.4800 | -189 | -8 | 0 | ||||
2024-02-02 | 2024-01-31 | 4 | Liu Xiang | BME | Common Stock | D | 189 | 189 | ||||||
2023-02-02 | 2023-01-31 | 4 | Liu Xiang | BME | Common Stock | D | 43.5600 | -96 | -4 | 0 | ||||
2023-02-02 | 2023-01-31 | 4 | Liu Xiang | BME | Common Stock | D | 96 | 96 | ||||||
2023-02-02 | 2023-01-31 | 4 | McClements Kyle | BME | Common Stock | D | 43.5600 | -616 | -27 | 522 | ||||
2023-02-02 | 2023-01-31 | 4 | McClements Kyle | BME | Common Stock | D | 616 | 1,138 | ||||||
2023-02-02 | 2023-01-31 | 4 | Xie H Erin | BME | Common Stock | D | 43.5600 | -13,967 | -608 | 0 | ||||
2023-02-02 | 2023-01-31 | 4 | Xie H Erin | BME | Common Stock | D | 13,967 | 13,967 | ||||||
2023-02-02 | 2023-01-31 | 4 | Accettella Christopher | BME | Common Stock | D | 43.5600 | -206 | -9 | 722 | ||||
2023-02-02 | 2023-01-31 | 4 | Accettella Christopher | BME | Common Stock | D | 206 | 928 | ||||||
2023-02-02 | 2023-01-31 | 4 | Lee Jeffrey Gene | BME | Common Stock | D | 43.5600 | -205 | -9 | 0 | ||||
2023-02-02 | 2023-01-31 | 4 | Lee Jeffrey Gene | BME | Common Stock | D | 205 | 205 | ||||||
2022-02-03 | 2022-01-31 | 4 | McClements Kyle | BME | Phantom Shares | D | -287 | 0 | ||||||
2022-02-03 | 2022-01-31 | 4 | McClements Kyle | BME | Phantom Shares | D | -144 | 144 | ||||||
2022-02-03 | 2022-01-31 | 4 | McClements Kyle | BME | Phantom Shares | D | -201 | 401 | ||||||
2022-02-03 | 2022-01-31 | 4 | McClements Kyle | BME | Phantom Shares | D | 45.1000 | 707 | 32 | 707 | ||||
2022-02-03 | 2022-01-31 | 4 | McClements Kyle | BME | Common Stock | D | 45.1000 | -632 | -29 | 494 | ||||
2022-02-03 | 2022-01-31 | 4 | McClements Kyle | BME | Common Stock | D | 632 | 1,126 | ||||||
2022-02-03 | 2022-01-31 | 4 | Accettella Christopher | BME | Phantom Shares | D | -78 | 0 | ||||||
2022-02-03 | 2022-01-31 | 4 | Accettella Christopher | BME | Phantom Shares | D | -64 | 64 | ||||||
2022-02-03 | 2022-01-31 | 4 | Accettella Christopher | BME | Phantom Shares | D | -61 | 123 | ||||||
2022-02-03 | 2022-01-31 | 4 | Accettella Christopher | BME | Phantom Shares | D | 45.1000 | 208 | 9 | 208 | ||||
2022-02-03 | 2022-01-31 | 4 | Accettella Christopher | BME | Common Stock | D | 45.1000 | -203 | -9 | 684 | ||||
2022-02-03 | 2022-01-31 | 4 | Accettella Christopher | BME | Common Stock | D | 203 | 887 | ||||||
2022-02-02 | 2022-01-31 | 4 | Lee Jeffrey Gene | BME | Phantom Shares | D | -71 | 143 | ||||||
2022-02-02 | 2022-01-31 | 4 | Lee Jeffrey Gene | BME | Phantom Shares | D | 45.1000 | 364 | 16 | 364 | ||||
2022-02-02 | 2022-01-31 | 4 | Lee Jeffrey Gene | BME | Common Stock | D | 45.1000 | -71 | -3 | 0 | ||||
2022-02-02 | 2022-01-31 | 4 | Lee Jeffrey Gene | BME | Common Stock | D | 71 | 71 | ||||||
2022-02-02 | 2022-01-31 | 4 | Xie H Erin | BME | Phantom Shares | D | -7,518 | 0 | ||||||
2022-02-02 | 2022-01-31 | 4 | Xie H Erin | BME | Phantom Shares | D | -3,739 | 3,739 | ||||||
2022-02-02 | 2022-01-31 | 4 | Xie H Erin | BME | Phantom Shares | D | -4,359 | 8,719 | ||||||
2022-02-02 | 2022-01-31 | 4 | Xie H Erin | BME | Phantom Shares | D | 45.1000 | 15,174 | 684 | 15,174 | ||||
2022-02-02 | 2022-01-31 | 4 | Xie H Erin | BME | Common Stock | D | 45.1000 | -15,617 | -704 | 0 | ||||
2022-02-02 | 2022-01-31 | 4 | Xie H Erin | BME | Common Stock | D | 15,617 | 15,617 | ||||||
2022-02-02 | 2022-01-31 | 4 | Liu Xiang | BME | Phantom Shares | D | 45.1000 | 272 | 12 | 272 | ||||
2021-02-02 | 2021-01-29 | 4 | Accettella Christopher | BME | Phantom Shares | D | -93 | 0 | ||||||
2021-02-02 | 2021-01-29 | 4 | Accettella Christopher | BME | Phantom Shares | D | -74 | 74 | ||||||
2021-02-02 | 2021-01-29 | 4 | Accettella Christopher | BME | Phantom Shares | D | -60 | 121 | ||||||
2021-02-02 | 2021-01-29 | 4 | Accettella Christopher | BME | Phantom Shares | D | 47.8800 | 175 | 8 | 175 | ||||
2021-02-02 | 2021-01-29 | 4 | Accettella Christopher | BME | Common Stock | D | 47.8800 | -228 | -11 | 649 | ||||
2021-02-02 | 2021-01-29 | 4 | Accettella Christopher | BME | Common Stock | D | 228 | 877 | ||||||
2021-02-02 | 2021-01-29 | 4 | McClements Kyle | BME | Phantom Shares | D | -366 | 0 | ||||||
2021-02-02 | 2021-01-29 | 4 | McClements Kyle | BME | Phantom Shares | D | -273 | 273 | ||||||
2021-02-02 | 2021-01-29 | 4 | McClements Kyle | BME | Phantom Shares | D | -137 | 274 | ||||||
2021-02-02 | 2021-01-29 | 4 | McClements Kyle | BME | Phantom Shares | D | 47.8800 | 572 | 27 | 572 | ||||
2021-02-02 | 2021-01-29 | 4 | McClements Kyle | BME | Common Stock | D | 47.8800 | -776 | -37 | 469 | ||||
2021-02-02 | 2021-01-29 | 4 | McClements Kyle | BME | Common Stock | D | 776 | 1,245 | ||||||
2021-02-02 | 2021-01-29 | 4 | Lee Jeffrey Gene | BME | Phantom Shares | D | 47.8800 | 204 | 10 | 204 | ||||
2021-02-02 | 2021-01-29 | 4 | Xie H Erin | BME | Phantom Shares | D | -3,172 | 0 | ||||||
2021-02-02 | 2021-01-29 | 4 | Xie H Erin | BME | Phantom Shares | D | -7,143 | 7,143 | ||||||
2021-02-02 | 2021-01-29 | 4 | Xie H Erin | BME | Phantom Shares | D | -3,553 | 7,105 | ||||||
2021-02-02 | 2021-01-29 | 4 | Xie H Erin | BME | Phantom Shares | D | 47.8800 | 12,425 | 595 | 12,425 | ||||
2021-02-02 | 2021-01-29 | 4 | Xie H Erin | BME | Common Stock | D | 47.8800 | -13,867 | -664 | 0 | ||||
2021-02-02 | 2021-01-29 | 4 | Xie H Erin | BME | Common Stock | D | 13,867 | 13,867 | ||||||
2020-02-04 | 2020-01-31 | 4 | McClements Kyle | BME | Phantom Shares | D | -346 | 346 | ||||||
2020-02-04 | 2020-01-31 | 4 | McClements Kyle | BME | Phantom Shares | D | -258 | 516 | ||||||
2020-02-04 | 2020-01-31 | 4 | McClements Kyle | BME | Phantom Shares | D | 41.1200 | 393 | 16 | 393 | ||||
2020-02-04 | 2020-01-31 | 4 | McClements Kyle | BME | Common Stock | D | 41.1200 | -604 | -25 | 443 | ||||
2020-02-04 | 2020-01-31 | 4 | McClements Kyle | BME | Common Stock | D | 604 | 1,047 | ||||||
2020-02-04 | 2020-01-31 | 4 | Xie H Erin | BME | Phantom Shares | D | -1,641 | 0 | ||||||
2020-02-04 | 2020-01-31 | 4 | Xie H Erin | BME | Phantom Shares | D | -2,998 | 2,998 | ||||||
2020-02-04 | 2020-01-31 | 4 | Xie H Erin | BME | Phantom Shares | D | -6,752 | 13,503 | ||||||
2020-02-04 | 2020-01-31 | 4 | Xie H Erin | BME | Phantom Shares | D | 41.1200 | 10,178 | 419 | 10,178 | ||||
2020-02-04 | 2020-01-31 | 4 | Xie H Erin | BME | Common Stock | D | 41.1200 | -11,391 | -468 | 0 | ||||
2020-02-04 | 2020-01-31 | 4 | Xie H Erin | BME | Common Stock | D | 11,391 | 11,391 | ||||||
2020-02-04 | 2020-01-31 | 4 | Accettella Christopher | BME | Phantom Shares | D | -88 | 88 | ||||||
2020-02-04 | 2020-01-31 | 4 | Accettella Christopher | BME | Phantom Shares | D | -70 | 140 | ||||||
2020-02-04 | 2020-01-31 | 4 | Accettella Christopher | BME | Phantom Shares | D | 41.1200 | 173 | 7 | 173 | ||||
2020-02-04 | 2020-01-31 | 4 | Accettella Christopher | BME | Common Stock | D | 41.1200 | -158 | -7 | 610 | ||||
2020-02-04 | 2020-01-31 | 4 | Accettella Christopher | BME | Common Stock | D | 158 | 769 | ||||||
2019-07-02 | 2019-06-28 | 4 | Egan Cynthia | BME | Common Stock | D | 38.9200 | 3,737 | 145 | 3,737 | ||||
2019-02-04 | 2019-01-31 | 4 | Xie H Erin | BME | Phantom Shares | D | -1,544 | 1,544 | ||||||
2019-02-04 | 2019-01-31 | 4 | Xie H Erin | BME | Phantom Shares | D | -2,820 | 5,640 | ||||||
2019-02-04 | 2019-01-31 | 4 | Xie H Erin | BME | Phantom Shares | D | 39.6700 | 19,052 | 756 | 19,052 | ||||
2019-02-04 | 2019-01-31 | 4 | Xie H Erin | BME | Common Stock | D | 39.6700 | -4,364 | -173 | 0 | ||||
2019-02-04 | 2019-01-31 | 4 | Xie H Erin | BME | Common Stock | D | 4,364 | 4,364 | ||||||
2019-02-04 | 2019-01-31 | 4 | McClements Kyle | BME | Phantom Shares | D | -325 | 651 | ||||||
2019-02-04 | 2019-01-31 | 4 | McClements Kyle | BME | Phantom Shares | D | 39.6700 | 728 | 29 | 728 | ||||
2019-02-04 | 2019-01-31 | 4 | McClements Kyle | BME | Common Stock | D | 39.6700 | -325 | -13 | 417 | ||||
2019-02-04 | 2019-01-31 | 4 | McClements Kyle | BME | Common Stock | D | 325 | 742 | ||||||
2019-02-04 | 2019-01-31 | 4 | Accettella Christopher | BME | Phantom Shares | D | -83 | 166 | ||||||
2019-02-04 | 2019-01-31 | 4 | Accettella Christopher | BME | Phantom Shares | D | 39.6700 | 198 | 8 | 198 | ||||
2019-02-04 | 2019-01-31 | 4 | Accettella Christopher | BME | Common Stock | D | 39.6700 | -83 | -3 | 577 | ||||
2019-02-04 | 2019-01-31 | 4 | Accettella Christopher | BME | Common Stock | D | 83 | 660 | ||||||
2018-10-17 | 2018-10-15 | 4 | KESTER W CARL | BME | Performance Rights | D | 41.2500 | 32 | 1 | 1,343 | ||||
2018-10-17 | 2018-10-15 | 4 | Lynch Catherine A. | BME | Performance Rights | D | 41.2500 | 50 | 2 | 474 | ||||
2018-10-17 | 2018-10-15 | 4 | ROBARDS KAREN P | BME | Performance Rights | D | 41.2500 | 17 | 1 | 619 | ||||
2018-10-17 | 2018-10-15 | 4 | Castellano Michael J | BME | Performance Rights | D | 41.2500 | 75 | 3 | 1,783 | ||||
2018-10-17 | 2018-10-15 | 4 | CAVANAGH RICHARD | BME | Performance Rights | D | 41.2500 | 109 | 5 | 1,691 | ||||
2018-10-17 | 2018-10-15 | 4 | HUBBARD ROBERT GLENN | BME | Performance Rights | D | 41.2500 | 125 | 5 | 2,941 | ||||
2018-07-17 | 2018-07-13 | 4 | HUBBARD ROBERT GLENN | BME | Performance Rights | D | 41.1700 | 126 | 5 | 2,773 | ||||
2018-07-17 | 2018-07-13 | 4 | KESTER W CARL | BME | Performance Rights | D | 41.1700 | 32 | 1 | 1,291 | ||||
2018-07-17 | 2018-07-13 | 4 | Lynch Catherine A. | BME | Performance Rights | D | 41.1700 | 50 | 2 | 418 | ||||
2018-07-17 | 2018-07-13 | 4 | ROBARDS KAREN P | BME | Performance Rights | D | 41.1700 | 17 | 1 | 593 | ||||
2018-07-17 | 2018-07-13 | 4 | Castellano Michael J | BME | Performance Rights | D | 41.1700 | 75 | 3 | 1,682 | ||||
2018-07-17 | 2018-07-13 | 4 | CAVANAGH RICHARD | BME | Performance Rights | D | 41.1700 | 109 | 5 | 1,557 | ||||
2018-04-17 | 2018-04-13 | 4 | Lynch Catherine A. | BME | Performance Rights | D | 34.5200 | 59 | 2 | 362 | ||||
2018-04-17 | 2018-04-13 | 4 | ROBARDS KAREN P | BME | Performance Rights | D | 34.5200 | 20 | 1 | 567 | ||||
2018-04-17 | 2018-04-13 | 4 | Castellano Michael J | BME | Performance Rights | D | 34.5200 | 89 | 3 | 1,581 | ||||
2018-04-17 | 2018-04-13 | 4 | CAVANAGH RICHARD | BME | Performance Rights | D | 34.5200 | 130 | 5 | 1,424 | ||||
2018-04-17 | 2018-04-13 | 4 | HUBBARD ROBERT GLENN | BME | Performance Rights | D | 34.5200 | 150 | 5 | 2,604 | ||||
2018-04-17 | 2018-04-13 | 4 | KESTER W CARL | BME | Performance Rights | D | 34.5200 | 38 | 1 | 1,238 | ||||
2018-02-02 | 2018-01-31 | 4 | McClements Kyle | BME | Phantom Shares | D | 36.2100 | 916 | 33 | 916 | ||||
2018-02-02 | 2018-01-31 | 4 | Accettella Christopher | BME | Phantom Shares | D | 36.2100 | 234 | 8 | 234 | ||||
2018-02-02 | 2018-01-31 | 4 | Xie H Erin | BME | Phantom Shares | D | -1,450 | 2,899 | ||||||
2018-02-02 | 2018-01-31 | 4 | Xie H Erin | BME | Phantom Shares | D | 36.2100 | 7,946 | 288 | 7,946 | ||||
2018-02-02 | 2018-01-31 | 4 | Xie H Erin | BME | Common Stock | D | 36.2100 | -1,450 | -52 | 0 | ||||
2018-02-02 | 2018-01-31 | 4 | Xie H Erin | BME | Common Stock | D | 1,450 | 1,450 | ||||||
2018-01-17 | 2018-01-12 | 4 | Lynch Catherine A. | BME | Performance Rights | D | 36.5900 | 56 | 2 | 298 | ||||
2018-01-17 | 2018-01-12 | 4 | ROBARDS KAREN P | BME | Performance Rights | D | 36.5900 | 19 | 1 | 538 | ||||
2018-01-17 | 2018-01-12 | 4 | Castellano Michael J | BME | Performance Rights | D | 36.5900 | 84 | 3 | 1,467 | ||||
2018-01-17 | 2018-01-12 | 4 | CAVANAGH RICHARD | BME | Performance Rights | D | 36.5900 | 123 | 5 | 1,272 | ||||
2018-01-17 | 2018-01-12 | 4 | HUBBARD ROBERT GLENN | BME | Performance Rights | D | 36.5900 | 141 | 5 | 2,413 | ||||
2018-01-17 | 2018-01-12 | 4 | KESTER W CARL | BME | Performance Rights | D | 36.5900 | 36 | 1 | 1,179 | ||||
2017-10-17 | 2017-10-13 | 4 | CAVANAGH RICHARD | BME | Performance Rights | D | 36.7000 | 93 | 3 | 1,130 | ||||
2017-10-17 | 2017-10-13 | 4 | Harris Jerrold B | BME | Performance Rights | D | 36.7000 | 152 | 6 | 2,373 | ||||
2017-10-17 | 2017-10-13 | 4 | HUBBARD ROBERT GLENN | BME | Performance Rights | D | 36.7000 | 141 | 5 | 2,234 | ||||
2017-10-17 | 2017-10-13 | 4 | KESTER W CARL | BME | Performance Rights | D | 36.7000 | 36 | 1 | 1,124 | ||||
2017-10-17 | 2017-10-13 | 4 | Lynch Catherine A. | BME | Performance Rights | D | 36.7000 | 56 | 2 | 238 | ||||
2017-10-17 | 2017-10-13 | 4 | ROBARDS KAREN P | BME | Performance Rights | D | 36.7000 | 37 | 1 | 510 | ||||
2017-10-17 | 2017-10-13 | 4 | Castellano Michael J | BME | Performance Rights | D | 36.7000 | 84 | 3 | 1,360 | ||||
2017-07-18 | 2017-07-14 | 4 | Lynch Catherine A. | BME | Performance Rights | D | 37.1900 | 55 | 2 | 179 | ||||
2017-07-18 | 2017-07-14 | 4 | ROBARDS KAREN P | BME | Performance Rights | D | 37.1900 | 37 | 1 | 465 | ||||
2017-07-18 | 2017-07-14 | 4 | KESTER W CARL | BME | Performance Rights | D | 37.1900 | 36 | 1 | 1,070 | ||||
2017-07-18 | 2017-07-14 | 4 | HUBBARD ROBERT GLENN | BME | Performance Rights | D | 37.1900 | 139 | 5 | 2,058 | ||||
2017-07-18 | 2017-07-14 | 4 | CAVANAGH RICHARD | BME | Performance Rights | D | 37.1900 | 92 | 3 | 1,019 | ||||
2017-07-18 | 2017-07-14 | 4 | Harris Jerrold B | BME | Performance Rights | D | 37.1900 | 150 | 6 | 2,184 | ||||
2017-07-18 | 2017-07-14 | 4 | Castellano Michael J | BME | Performance Rights | D | 37.1900 | 83 | 3 | 1,255 | ||||
2017-04-17 | 2017-04-13 | 4 | ROBARDS KAREN P | BME | Performance Rights | D | 34.2100 | 40 | 1 | 421 | ||||
2017-04-17 | 2017-04-13 | 4 | KESTER W CARL | BME | Performance Rights | D | 34.2100 | 39 | 1 | 1,016 | ||||
2017-04-17 | 2017-04-13 | 4 | HUBBARD ROBERT GLENN | BME | Performance Rights | D | 34.2100 | 151 | 5 | 1,886 | ||||
2017-04-17 | 2017-04-13 | 4 | Lynch Catherine A. | BME | Performance Rights | D | 34.2100 | 60 | 2 | 122 | ||||
2017-04-17 | 2017-04-13 | 4 | Harris Jerrold B | BME | Performance Rights | D | 34.2100 | 163 | 6 | 1,999 | ||||
2017-04-17 | 2017-04-13 | 4 | CAVANAGH RICHARD | BME | Performance Rights | D | 34.2100 | 100 | 3 | 912 | ||||
2017-04-17 | 2017-04-13 | 4 | Castellano Michael J | BME | Performance Rights | D | 34.2100 | 90 | 3 | 1,152 | ||||
2017-03-27 | 2017-01-31 | 4 | Xie H Erin | BME | Phantom Shares | D | 33.1200 | 4,062 | 135 | 4,062 | ||||
2017-01-18 | 2017-01-13 | 4 | CAVANAGH RICHARD | BME | Performance Rights | D | 33.6500 | 101 | 3 | 798 | ||||
2017-01-18 | 2017-01-13 | 4 | HUBBARD ROBERT GLENN | BME | Performance Rights | D | 33.6500 | 153 | 5 | 1,705 | ||||
2017-01-18 | 2017-01-13 | 4 | KESTER W CARL | BME | Performance Rights | D | 33.6500 | 39 | 1 | 961 | ||||
2017-01-18 | 2017-01-13 | 4 | ROBARDS KAREN P | BME | Performance Rights | D | 33.6500 | 41 | 1 | 374 | ||||
2017-01-18 | 2017-01-13 | 4 | Castellano Michael J | BME | Performance Rights | D | 33.6500 | 91 | 3 | 1,044 | ||||
2017-01-18 | 2017-01-13 | 4 | Harris Jerrold B | BME | Performance Rights | D | 33.6500 | 166 | 6 | 1,804 | ||||
2017-01-18 | 2017-01-13 | 4 | Lynch Catherine A. | BME | Performance Rights | D | 33.6500 | 61 | 2 | 61 | ||||
2016-10-18 | 2016-10-14 | 4 | CAVANAGH RICHARD | BME | Performance Rights | D | 33.4300 | 41 | 1 | 672 | ||||
2016-10-18 | 2016-10-14 | 4 | HUBBARD ROBERT GLENN | BME | Performance Rights | D | 33.4300 | 154 | 5 | 1,495 | ||||
2016-10-18 | 2016-10-14 | 4 | KESTER W CARL | BME | Performance Rights | D | 33.4300 | 91 | 3 | 888 | ||||
2016-10-18 | 2016-10-14 | 4 | ROBARDS KAREN P | BME | Performance Rights | D | 33.4300 | 20 | 1 | 321 | ||||
2016-10-18 | 2016-10-14 | 4 | Castellano Michael J | BME | Performance Rights | D | 33.4300 | 92 | 3 | 918 | ||||
2016-10-18 | 2016-10-14 | 4 | Harris Jerrold B | BME | Performance Rights | D | 33.4300 | 167 | 6 | 1,579 | ||||
2016-07-19 | 2016-07-15 | 4 | ROBARDS KAREN P | BME | Performance Rights | D | 35.4800 | 19 | 1 | 296 | ||||
2016-07-19 | 2016-07-15 | 4 | HUBBARD ROBERT GLENN | BME | Performance Rights | D | 35.4800 | 145 | 5 | 1,319 | ||||
2016-07-19 | 2016-07-15 | 4 | CAVANAGH RICHARD | BME | Performance Rights | D | 35.4800 | 37 | 1 | 620 | ||||
2016-07-19 | 2016-07-15 | 4 | KESTER W CARL | BME | Performance Rights | D | 35.4800 | 85 | 3 | 784 | ||||
2016-07-19 | 2016-07-15 | 4 | Castellano Michael J | BME | Performance Rights | D | 35.4800 | 86 | 3 | 812 | ||||
2016-07-19 | 2016-07-15 | 4 | Harris Jerrold B | BME | Performance Rights | D | 35.4800 | 157 | 6 | 1,389 | ||||
2016-04-19 | 2016-04-15 | 4 | CAVANAGH RICHARD | BME | Performance Rights | D | 36.7600 | 37 | 1 | 574 | ||||
2016-04-19 | 2016-04-15 | 4 | ROBARDS KAREN P | BME | Performance Rights | D | 36.7600 | 19 | 1 | 272 | ||||
2016-04-19 | 2016-04-15 | 4 | HUBBARD ROBERT GLENN | BME | Performance Rights | D | 36.7600 | 140 | 5 | 1,154 | ||||
2016-04-19 | 2016-04-15 | 4 | KESTER W CARL | BME | Performance Rights | D | 36.7600 | 83 | 3 | 687 | ||||
2016-04-19 | 2016-04-15 | 4 | Castellano Michael J | BME | Performance Rights | D | 36.7600 | 83 | 3 | 714 | ||||
2016-04-19 | 2016-04-15 | 4 | Harris Jerrold B | BME | Performance Rights | D | 36.7600 | 151 | 6 | 1,212 | ||||
2016-01-20 | 2016-01-15 | 4 | Castellano Michael J | BME | Performance Rights | D | 37.0400 | 83 | 3 | 620 | ||||
2016-01-20 | 2016-01-15 | 4 | Harris Jerrold B | BME | Performance Rights | D | 37.0400 | 150 | 6 | 1,043 | ||||
2016-01-20 | 2016-01-15 | 4 | CAVANAGH RICHARD | BME | Performance Rights | D | 37.0400 | 41 | 2 | 527 | ||||
2016-01-20 | 2016-01-15 | 4 | HUBBARD ROBERT GLENN | BME | Performance Rights | D | 37.0400 | 139 | 5 | 997 | ||||
2016-01-20 | 2016-01-15 | 4 | KESTER W CARL | BME | Performance Rights | D | 37.0400 | 82 | 3 | 594 | ||||
2016-01-20 | 2016-01-15 | 4 | ROBARDS KAREN P | BME | Performance Rights | D | 37.0400 | 20 | 1 | 249 | ||||
2015-10-19 | 2015-10-15 | 4 | Harris Jerrold B | BME | Performance Rights | D | 40.2500 | 138 | 6 | 879 | ||||
2015-10-19 | 2015-10-15 | 4 | HUBBARD ROBERT GLENN | BME | Performance Rights | D | 40.2500 | 128 | 5 | 846 | ||||
2015-10-19 | 2015-10-15 | 4 | Castellano Michael J | BME | Performance Rights | D | 40.2500 | 76 | 3 | 529 | ||||
2015-10-19 | 2015-10-15 | 4 | FELDSTEIN KATHLEEN F | BME | Performance Rights | D | 40.2500 | 72 | 3 | 484 | ||||
2015-10-19 | 2015-10-15 | 4 | FLYNN JAMES T | BME | Performance Rights | D | 40.2500 | 127 | 5 | 882 | ||||
2015-10-19 | 2015-10-15 | 4 | KESTER W CARL | BME | Performance Rights | D | 40.2500 | 66 | 3 | 505 | ||||
2015-10-19 | 2015-10-15 | 4 | ROBARDS KAREN P | BME | Performance Rights | D | 40.2500 | 34 | 1 | 226 | ||||
2015-10-19 | 2015-10-15 | 4 | FABOZZI FRANK | BME | Performance Rights | D | 40.2500 | 14 | 1 | 142 | ||||
2015-10-19 | 2015-10-15 | 4 | CAVANAGH RICHARD | BME | Performance Rights | D | 40.2500 | 72 | 3 | 479 | ||||
2015-07-16 | 2015-07-15 | 4 | Castellano Michael J | BME | Performance Rights | D | 44.8800 | 61 | 3 | 447 | ||||
2015-07-16 | 2015-07-15 | 4 | Harris Jerrold B | BME | Performance Rights | D | 44.8800 | 99 | 4 | 732 | ||||
2015-07-16 | 2015-07-15 | 4 | HUBBARD ROBERT GLENN | BME | Performance Rights | D | 44.8800 | 96 | 4 | 708 | ||||
2015-07-16 | 2015-07-15 | 4 | FABOZZI FRANK | BME | Performance Rights | D | 44.8800 | 11 | 0 | 126 | ||||
2015-07-16 | 2015-07-15 | 4 | CAVANAGH RICHARD | BME | Performance Rights | D | 44.8800 | 55 | 2 | 402 | ||||
2015-07-16 | 2015-07-15 | 4 | FELDSTEIN KATHLEEN F | BME | Performance Rights | D | 44.8800 | 55 | 2 | 407 | ||||
2015-07-16 | 2015-07-15 | 4 | FLYNN JAMES T | BME | Performance Rights | D | 44.8800 | 101 | 5 | 745 | ||||
2015-07-16 | 2015-07-15 | 4 | KESTER W CARL | BME | Performance Rights | D | 44.8800 | 59 | 3 | 434 | ||||
2015-07-16 | 2015-07-15 | 4 | ROBARDS KAREN P | BME | Performance Rights | D | 44.8800 | 26 | 1 | 190 | ||||
2015-04-17 | 2015-04-15 | 4 | FABOZZI FRANK | BME | Performance Rights | D | 43.1400 | 11 | 0 | 114 | ||||
2015-04-17 | 2015-04-15 | 4 | FLYNN JAMES T | BME | Performance Rights | D | 43.1400 | 105 | 5 | 637 | ||||
2015-04-17 | 2015-04-15 | 4 | ROBARDS KAREN P | BME | Performance Rights | D | 43.1400 | 27 | 1 | 162 | ||||
2015-04-17 | 2015-04-15 | 4 | FELDSTEIN KATHLEEN F | BME | Performance Rights | D | 43.1400 | 57 | 2 | 348 | ||||
2015-04-17 | 2015-04-15 | 4 | HUBBARD ROBERT GLENN | BME | Performance Rights | D | 43.1400 | 100 | 4 | 606 | ||||
2015-04-17 | 2015-04-15 | 4 | CAVANAGH RICHARD | BME | Performance Rights | D | 43.1400 | 57 | 2 | 344 | ||||
2015-04-17 | 2015-04-15 | 4 | KESTER W CARL | BME | Performance Rights | D | 43.1400 | 61 | 3 | 371 | ||||
2015-04-17 | 2015-04-15 | 4 | Castellano Michael J | BME | Performance Rights | D | 43.1400 | 63 | 3 | 382 | ||||
2015-04-17 | 2015-04-15 | 4 | Harris Jerrold B | BME | Performance Rights | D | 43.1400 | 103 | 4 | 625 | ||||
2015-01-20 | 2015-01-15 | 4 | HUBBARD ROBERT GLENN | BME | Performance Rights | D | 40.5000 | 106 | 4 | 501 | ||||
2015-01-20 | 2015-01-15 | 4 | Harris Jerrold B | BME | Performance Rights | D | 40.5000 | 110 | 4 | 516 | ||||
2015-01-20 | 2015-01-15 | 4 | Castellano Michael J | BME | Performance Rights | D | 40.5000 | 67 | 3 | 315 | ||||
2015-01-20 | 2015-01-15 | 4 | FELDSTEIN KATHLEEN F | BME | Performance Rights | D | 40.5000 | 61 | 2 | 287 | ||||
2015-01-20 | 2015-01-15 | 4 | FLYNN JAMES T | BME | Performance Rights | D | 40.5000 | 112 | 5 | 526 | ||||
2015-01-20 | 2015-01-15 | 4 | KESTER W CARL | BME | Performance Rights | D | 40.5000 | 65 | 3 | 306 | ||||
2015-01-20 | 2015-01-15 | 4 | ROBARDS KAREN P | BME | Performance Rights | D | 40.5000 | 29 | 1 | 134 | ||||
2015-01-20 | 2015-01-15 | 4 | FABOZZI FRANK | BME | Performance Rights | D | 40.5000 | 12 | 0 | 102 | ||||
2015-01-20 | 2015-01-15 | 4 | CAVANAGH RICHARD | BME | Performance Rights | D | 40.5000 | 60 | 2 | 284 | ||||
2014-12-11 | 2014-12-09 | 4 | GABBAY HENRY | BME | Common Stock | D | 42.1916 | -650 | -27 | 0 | ||||
2014-12-09 | 2014-12-05 | 4 | CAVANAGH RICHARD | BME | Performance Rights | D | 42.9500 | 1 | 0 | 210 | ||||
2014-12-09 | 2014-12-05 | 4 | HUBBARD ROBERT GLENN | BME | Performance Rights | D | 42.9500 | 4 | 0 | 370 | ||||
2014-12-09 | 2014-12-05 | 4 | FELDSTEIN KATHLEEN F | BME | Performance Rights | D | 42.9500 | 1 | 0 | 212 | ||||
2014-12-09 | 2014-12-05 | 4 | FABOZZI FRANK | BME | Performance Rights | D | 42.9500 | 1 | 0 | 84 | ||||
2014-10-17 | 2014-10-15 | 4 | FABOZZI FRANK | BME | Performance Rights | D | 36.0100 | 27 | 1 | 82 | ||||
2014-10-17 | 2014-10-15 | 4 | FLYNN JAMES T | BME | Performance Rights | D | 36.0100 | 126 | 5 | 384 | ||||
2014-10-17 | 2014-10-15 | 4 | ROBARDS KAREN P | BME | Performance Rights | D | 36.0100 | 32 | 1 | 98 | ||||
2014-10-17 | 2014-10-15 | 4 | FELDSTEIN KATHLEEN F | BME | Performance Rights | D | 36.0100 | 69 | 2 | 210 | ||||
2014-10-17 | 2014-10-15 | 4 | HUBBARD ROBERT GLENN | BME | Performance Rights | D | 36.0100 | 119 | 4 | 363 | ||||
2014-10-17 | 2014-10-15 | 4 | CAVANAGH RICHARD | BME | Performance Rights | D | 36.0100 | 68 | 2 | 207 | ||||
2014-10-17 | 2014-10-15 | 4 | KESTER W CARL | BME | Performance Rights | D | 36.0100 | 73 | 3 | 224 | ||||
2014-10-17 | 2014-10-15 | 4 | Castellano Michael J | BME | Performance Rights | D | 36.0100 | 76 | 3 | 231 | ||||
2014-10-17 | 2014-10-15 | 4 | Harris Jerrold B | BME | Performance Rights | D | 36.0100 | 124 | 4 | 377 | ||||
2014-07-17 | 2014-07-15 | 4 | FABOZZI FRANK | BME | Performance Rights | D | 36.4000 | 27 | 1 | 55 | ||||
2014-07-17 | 2014-07-15 | 4 | FLYNN JAMES T | BME | Performance Rights | D | 36.4000 | 125 | 5 | 257 | ||||
2014-07-17 | 2014-07-15 | 4 | HUBBARD ROBERT GLENN | BME | Performance Rights | D | 36.4000 | 118 | 4 | 243 | ||||
2014-07-17 | 2014-07-15 | 4 | ROBARDS KAREN P | BME | Performance Rights | D | 36.4000 | 32 | 1 | 65 | ||||
2014-07-17 | 2014-07-15 | 4 | CAVANAGH RICHARD | BME | Performance Rights | D | 36.4000 | 67 | 2 | 138 | ||||
2014-07-17 | 2014-07-15 | 4 | FELDSTEIN KATHLEEN F | BME | Performance Rights | D | 36.4000 | 68 | 2 | 140 | ||||
2014-07-17 | 2014-07-15 | 4 | KESTER W CARL | BME | Performance Rights | D | 36.4000 | 73 | 3 | 150 | ||||
2014-07-17 | 2014-07-15 | 4 | Castellano Michael J | BME | Performance Rights | D | 36.4000 | 75 | 3 | 154 | ||||
2014-07-17 | 2014-07-15 | 4 | Harris Jerrold B | BME | Performance Rights | D | 36.4000 | 123 | 4 | 252 | ||||
2014-04-17 | 2014-04-15 | 4 | HUBBARD ROBERT GLENN | BME | Performance Rights | D | 34.9100 | 123 | 4 | 123 | ||||
2014-04-17 | 2014-04-15 | 4 | CAVANAGH RICHARD | BME | Performance Rights | D | 34.9100 | 70 | 2 | 70 | ||||
2014-04-17 | 2014-04-15 | 4 | KESTER W CARL | BME | Performance Rights | D | 34.9100 | 76 | 3 | 76 | ||||
2014-04-17 | 2014-04-15 | 4 | FLYNN JAMES T | BME | Performance Rights | D | 34.9100 | 130 | 5 | 130 | ||||
2014-04-17 | 2014-04-15 | 4 | FABOZZI FRANK | BME | Performance Rights | D | 34.9100 | 28 | 1 | 28 | ||||
2014-04-17 | 2014-04-15 | 4 | FELDSTEIN KATHLEEN F | BME | Performance Rights | D | 34.9100 | 71 | 2 | 71 | ||||
2014-04-17 | 2014-04-15 | 4 | ROBARDS KAREN P | BME | Performance Rights | D | 34.9100 | 33 | 1 | 33 | ||||
2014-04-17 | 2014-04-15 | 4 | Castellano Michael J | BME | Performance Rights | D | 34.9100 | 78 | 3 | 78 | ||||
2014-04-17 | 2014-04-15 | 4 | Harris Jerrold B | BME | Performance Rights | D | 34.9100 | 128 | 4 | 128 | ||||
2012-09-19 | 2012-09-19 | 4 | Castellano Michael J | BME | Common Stock | D | 27.7099 | 400 | 11 | 400 | ||||
2012-09-14 | 3 | Accettella Christopher | BME | Common Stock | D | 304 | ||||||||
2005-12-16 | 2005-12-06 | 4/A | McClements Kyle | BME | Common Stock | D | 25.3600 | 100 | 3 | 100 | ||||
2005-12-08 | 2005-12-06 | 4 | McClements Kyle | BME | Common Stock | D | 25.3600 | 100 | 3 | 100 |